Cargando...
Anti-CD73 in cancer immunotherapy: awakening new opportunities
In recent years, cancer immunotherapy made significant advances due to a better understanding of the principles underlying tumor biology and immunology. In this context, CD73 is a key molecule, since via degradation of adenosine monophosphate into adenosine, endorses the generation of an immunosuppr...
Gardado en:
| Publicado en: | Trends Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4800751/ https://ncbi.nlm.nih.gov/pubmed/27014745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2016.01.003 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|